Form 8-K - Current report:
SEC Accession No. 0001193125-13-243333
Filing Date
2013-05-31
Accepted
2013-05-31 16:29:45
Documents
1
Period of Report
2013-05-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d545359d8k.htm 8-K 19020
  Complete submission text file 0001193125-13-243333.txt   20426
Mailing Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034
Business Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 13885317
SIC: 2834 Pharmaceutical Preparations